2024 Q2 Form 10-Q Financial Statement

#000162828024023056 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $25.83M $22.68M $19.67M
YoY Change 42.88% 15.29% 21.98%
Cost Of Revenue $21.28M $19.61M $17.07M
YoY Change 24.84% 14.9% 0.94%
Gross Profit $4.550M $3.064M $2.599M
YoY Change 340.46% 17.89% -430.66%
Gross Profit Margin 17.61% 13.51% 13.21%
Selling, General & Admin $4.035M $4.370M $3.748M
YoY Change 5.49% 16.6% -12.29%
% of Gross Profit 88.68% 142.62% 144.21%
Research & Development $0.00 $18.00K $278.0K
YoY Change -100.0% -93.53% -82.26%
% of Gross Profit 0.0% 0.59% 10.7%
Depreciation & Amortization $400.0K $545.0K $160.0K
YoY Change 100.0% 240.63% 15.94%
% of Gross Profit 8.79% 17.79% 6.16%
Operating Expenses $4.035M $4.388M $4.026M
YoY Change 1.08% 8.99% -31.06%
Operating Profit $515.0K -$1.324M -$1.427M
YoY Change -117.4% -7.22% -78.46%
Interest Expense -$172.0K $431.0K $387.0K
YoY Change -143.54% 11.37% -28.33%
% of Operating Profit -33.4%
Other Income/Expense, Net -$172.0K -$407.0K -$323.0K
YoY Change -50.29% 26.01% -39.74%
Pretax Income $343.0K -$1.731M -$1.750M
YoY Change -110.38% -1.09% -75.57%
Income Tax
% Of Pretax Income
Net Earnings $343.0K -$1.731M -$1.750M
YoY Change -110.38% -1.09% -75.57%
Net Earnings / Revenue 1.33% -7.63% -8.9%
Basic Earnings Per Share $0.01 -$0.06 -$0.10
Diluted Earnings Per Share $0.01 -$0.06 -$0.10
COMMON SHARES
Basic Shares Outstanding 30.32M shares 29.33M shares 12.55M shares
Diluted Shares Outstanding 32.03M shares 29.33M shares 18.36M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.86M $8.619M $16.83M
YoY Change -20.2% -48.8% 70.04%
Cash & Equivalents $11.86M $6.642M $10.89M
Short-Term Investments $0.00 $1.977M $5.940M
Other Short-Term Assets $1.167M $910.0K $1.240M
YoY Change -20.88% -26.61% -44.42%
Inventory $5.883M $6.073M $5.595M
Prepaid Expenses
Receivables $10.84M $11.09M $6.021M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.75M $26.70M $29.69M
YoY Change 7.94% -10.08% 19.73%
LONG-TERM ASSETS
Property, Plant & Equipment $6.009M $6.134M $2.179M
YoY Change 187.1% 181.51% -8.33%
Goodwill $921.0K $921.0K $921.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles $10.48M $10.62M
YoY Change
Long-Term Investments
YoY Change
Other Assets $548.0K $527.0K $522.0K
YoY Change 3.98% 0.96% -15.53%
Total Long-Term Assets $23.28M $24.03M $10.78M
YoY Change 122.26% 122.84% -14.69%
TOTAL ASSETS
Total Short-Term Assets $29.75M $26.70M $29.69M
Total Long-Term Assets $23.28M $24.03M $10.78M
Total Assets $53.03M $50.72M $40.47M
YoY Change 39.41% 25.33% 8.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.347M $4.919M $5.202M
YoY Change -43.53% -5.44% 23.15%
Accrued Expenses $6.168M $5.253M $4.359M
YoY Change 63.91% 20.51% -0.32%
Deferred Revenue $46.00K $46.00K $259.0K
YoY Change -82.24% -82.24% -88.03%
Short-Term Debt $670.0K $0.00 $0.00
YoY Change -8.59%
Long-Term Debt Due $576.0K $566.0K $3.131M
YoY Change -87.56% -81.92% -52.78%
Total Short-Term Liabilities $14.89M $14.95M $15.07M
YoY Change -14.67% -0.8% -23.09%
LONG-TERM LIABILITIES
Long-Term Debt $8.295M $8.265M $6.147M
YoY Change 75.0% 34.46% -47.81%
Other Long-Term Liabilities $14.00K $14.00K $14.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $8.309M $8.279M $6.161M
YoY Change 74.78% 34.38% -47.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.89M $14.95M $15.07M
Total Long-Term Liabilities $8.309M $8.279M $6.161M
Total Liabilities $29.53M $30.08M $27.93M
YoY Change 3.58% 7.7% -33.88%
SHAREHOLDERS EQUITY
Retained Earnings -$398.6M -$398.9M -$390.5M
YoY Change 1.21% 2.16% 3.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.50M $20.64M $12.54M
YoY Change
Total Liabilities & Shareholders Equity $53.03M $50.72M $40.47M
YoY Change 39.41% 25.33% 8.11%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $343.0K -$1.731M -$1.750M
YoY Change -110.38% -1.09% -75.57%
Depreciation, Depletion And Amortization $400.0K $545.0K $160.0K
YoY Change 100.0% 240.63% 15.94%
Cash From Operating Activities $1.442M -$2.400M -$3.900M
YoY Change -183.06% -38.46% -60.2%
INVESTING ACTIVITIES
Capital Expenditures $286.0K $139.0K -$52.00K
YoY Change 281.33% -367.31% 79.31%
Acquisitions
YoY Change
Other Investing Activities $2.003M $0.00 $10.86M
YoY Change 15307.69% -100.0% 18.58%
Cash From Investing Activities $1.717M -$139.0K $5.302M
YoY Change -2869.35% -102.62% -41.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.065M $178.0K -$631.0K
YoY Change -1676.34% -128.21% -76.52%
NET CHANGE
Cash From Operating Activities 1.442M -$2.400M -$3.900M
Cash From Investing Activities 1.717M -$139.0K $5.302M
Cash From Financing Activities 2.065M $178.0K -$631.0K
Net Change In Cash 5.224M -$2.341M $792.0K
YoY Change -370.81% -395.58% -123.53%
FREE CASH FLOW
Cash From Operating Activities $1.442M -$2.400M -$3.900M
Capital Expenditures $286.0K $139.0K -$52.00K
Free Cash Flow $1.156M -$2.539M -$3.848M
YoY Change -163.83% -34.02% -60.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
500000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17069000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2599000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1731000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
244000 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15000 shares
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19612000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
3064000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
278000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
594000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
498000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3776000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3250000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1324000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1427000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
431000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
387000 usd
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
24000 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
64000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-407000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-323000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1731000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29327204 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29327204 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18359940 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18359940 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1731000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
25000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-3000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1706000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1757000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
21291000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
25000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
247000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
251000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
20643000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14106000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-3000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
193000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12542000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
545000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
160000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
251000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
193000 usd
CY2024Q1 rmti Operating And Finance Lease Right Of Use Asset Amortization Expense
OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense
519000 usd
CY2023Q1 rmti Operating And Finance Lease Right Of Use Asset Amortization Expense
OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense
485000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
219000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
92000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
193000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-238000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
202000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-219000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-153000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-505000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
403000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1149000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-395000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-336000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1938000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3295000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-11000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1537000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2380000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3876000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2053000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
7500000 usd
CY2024Q1 rmti Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition
PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition
139000 usd
CY2023Q1 rmti Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition
PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition
145000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-139000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5302000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
244000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
503000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
138000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
128000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
560000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-631000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2341000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
792000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8983000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10102000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6642000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10894000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
234000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
295000 usd
CY2024Q1 rmti Warrant Issued
WarrantIssued
247000 usd
CY2023Q1 rmti Warrant Issued
WarrantIssued
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
25000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3000 usd
CY2024Q1 rmti Area Of Operating Space
AreaOfOperatingSpace
175000 sqft
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8600000 usd
CY2024Q1 rmti Working Capital Net
WorkingCapitalNet
11700000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2400000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1731000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1731000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1731000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1750000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1750000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29327204 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29327204 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18359940 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18359940 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7666260 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12879997 shares
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 rmti Average Payment Term Of Customers
AveragePaymentTermOfCustomers
P30D
CY2024Q1 rmti Average Payment Term Of Distributors
AveragePaymentTermOfDistributors
P60D
CY2024Q1 rmti Number Of Distribution And License Agreements
NumberOfDistributionAndLicenseAgreements
5 agreement
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22676000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19668000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
11094000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
10901000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
6259000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
510000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
521000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4331000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1500000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1948000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
29000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1977000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1948000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1952000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
2024000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2250000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
241000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
351000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3808000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3270000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
5900000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
25000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
25000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
6073000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
5871000 usd
CY2024Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
178000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
178000 usd
CY2024Q1 rmti Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
6251000 usd
CY2023Q4 rmti Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
6049000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
6100000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15345000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15206000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9211000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8804000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6134000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6402000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
400000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
200000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1507000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2413000 usd
CY2024Q1 rmti Accrued Unvouchered Receipts Current
AccruedUnvoucheredReceiptsCurrent
1164000 usd
CY2023Q4 rmti Accrued Unvouchered Receipts Current
AccruedUnvoucheredReceiptsCurrent
1663000 usd
CY2024Q1 rmti Accrued Manufacturing Expense Current
AccruedManufacturingExpenseCurrent
827000 usd
CY2023Q4 rmti Accrued Manufacturing Expense Current
AccruedManufacturingExpenseCurrent
1064000 usd
CY2024Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
219000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
254000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1536000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1755000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5253000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7149000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
15000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29556474 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29556474 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29130607 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29130607 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29556474 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12552673 shares
CY2024Q1 rmti Common Stock And Pre Funded Warrants Shares Outstanding
CommonStockAndPreFundedWarrantsSharesOutstanding
29556474 shares
CY2023Q1 rmti Common Stock And Pre Funded Warrants Shares Outstanding
CommonStockAndPreFundedWarrantsSharesOutstanding
18463673 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1876031 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1194202 shares
CY2024Q1 us-gaap Convertible Preferred Stock Shares Reserved For Future Issuance
ConvertiblePreferredStockSharesReservedForFutureIssuance
1363636 shares
CY2023Q1 us-gaap Convertible Preferred Stock Shares Reserved For Future Issuance
ConvertiblePreferredStockSharesReservedForFutureIssuance
1363636 shares
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
37222734 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
31343670 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
251000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
193000 usd
CY2018Q4 rmti Number Of Additional Agreements
NumberOfAdditionalAgreements
3 agreement
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
420000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
404000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
122000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
115000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
542000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
519000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
141000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
141000 usd
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
32000 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
39000 usd
CY2024Q1 rmti Finance Lease Expense
FinanceLeaseExpense
173000 usd
CY2023Q1 rmti Finance Lease Expense
FinanceLeaseExpense
180000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
720000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
703000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
437000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
424000 usd
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
32000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
39000 usd
CY2024Q1 rmti Cash Flows From Finance Lease Principal Payments
CashFlowsFromFinanceLeasePrincipalPayments
138000 usd
CY2023Q1 rmti Cash Flows From Finance Lease Principal Payments
CashFlowsFromFinanceLeasePrincipalPayments
128000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.064
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.064
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1261000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
503000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1587000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
676000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
946000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
666000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
525000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
311000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4321000 usd
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2156000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
353000 usd
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
206000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3968000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1950000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-023056-index-headers.html Edgar Link pending
0001628280-24-023056-index.html Edgar Link pending
0001628280-24-023056.txt Edgar Link pending
0001628280-24-023056-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmti-20240331.htm Edgar Link pending
rmti-20240331.xsd Edgar Link pending
rmti-20240331x10qex311.htm Edgar Link pending
rmti-20240331x10qex321.htm Edgar Link pending
Show.js Edgar Link pending
rmti-20240331_lab.xml Edgar Link unprocessable
rmti-20240331_pre.xml Edgar Link unprocessable
rmti-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rmti-20240331_cal.xml Edgar Link unprocessable
rmti-20240331_def.xml Edgar Link unprocessable